Medicine
Deuruxolitinib for Alopecia Areata.
Alexander Robbins, Mariana A. Phillips
2026.1.1Skin therapy letter
tlooto Summary
Deuruxolitinib is the third oral JAK inhibitor approved for the treatment of severe AA, the others being baricitinib and ritlecitinib.
Abstract
Abstract is not available.
Citation format
ROBBINS, Alexander; PHILLIPS, Mariana A. Deuruxolitinib for alopecia areata. Skin therapy letter, 2026, 31 1: 1.